1000306-34-2 Basic information More..
Product Name:KVI-020
Synonyms:KVI-020;WYE-160020;N-[(4R)-4-(4-methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxoimidazolidin-1-yl]methanesulfonamide;Methanesulfonamide, N-[(4R)-4-(4-methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-2-oxo-1-imidazolidinyl]-
CAS:1000306-34-2
MF:C20H25N3O5S
MW:419.49
EINECS:
Mol File:1000306-34-2.mol
1000306-34-2

KVI-020 manufacturers

  • KVI-020
  • US $3520.00-2785.00 / mg
  • 2025-04-30
  • CAS:1000306-34-2
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
Information Error Report
Your Email:
Browse by province 1000306-34-2 Suppliers Global suppliers
Shanghai(1) Anhui(1) Member(2) All(2)
1000306-34-2 Recommend Suppliers
Recommend You Select Member Companies...
Company Name: Hefei fuya biotechnology co. LTD      Recommend    Complaint
Tel:
FAX:
Email: sales02@foreversyn.com
Products Intro: Product Name:KVI-020
CAS:1000306-34-2
Purity:95% HPLC Package:1G;100G   More...
CB Index: 58
WebSite: http://www.purerechem.com
Related Information: Sales Network   Catalog(1961)   User Evaluation
Company Name: TargetMol Chemicals Inc.      Recommend    Complaint
Tel:
FAX:
Email: marketing@targetmol.cn
Products Intro: Product Name:KVI-020
CAS:1000306-34-2
Package:100mg/RMB 24625;25mg/RMB 14900;50mg/RMB 19420   More...
CB Index: 58
WebSite: https://www.targetmol.cn/
Related Information: Sales Network   Catalog(26998)   User Evaluation
1
Tag: 1000306-34-2
  • HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.